ERN-Skin recommendationsSee our multilingual recommendations for COVID-19 and rare skin diseases on the ERN-Skin website. COVID-19
Assay
A
new Covid19 Clinical Assay has been developed on rare skin diseases thanks to
our European and French Networks!
"COVID-19 and rare skin
diseases. European observational study (data research) during an epidemic". This
study concerns paediatric and adult patients with rare skin diseases and
suspected or confirmed COVID-19 infection who consult a medical team that is
part of the European Reference Network ERN-Skin or the Rare Skin Diseases Health
Network (FIMARAD). Professor Christine Bodemer (Hôpital Necker-Enfants malades,
Paris, France) is the principal investigator. The
main objective of this European observational cohort study (research
data) is to determine the impact of a COVID-19 virus infection in a cohort of
patients with rare skin diseases and particularly if these rare diseases and
their treatments are risk factors of infection severity. This
study is under registration on the following website : https://clinicaltrials.gov/
If
you have any other question, you can contact the ERN-Skin
CoordinationTeam : catherine.champseix@aphp.fr |